GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...
The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...
Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...
“As the first biosimilar to Simponi (golimumab) to gain approval in the European market, we are committed to expanding access ...
Poolbeg Pharma has announced that the European Patent Office has granted its European Immunomodulator II patent application ...
Protara Therapeutics has announced encouraging interim results from its ongoing phase 2 STARBORN-1 trial evaluating TARA-002 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback